We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Simple Urine Test Could Detect Multiple Cancers at Early Stage

By LabMedica International staff writers
Posted on 25 Jun 2025

When disease is present, the human body releases tiny molecules known as volatile organic compounds (VOCs). More...

Now, a spectroscopy and artificial intelligence (AI)-powered urine-based test uses scent-based technology for the routine and noninvasive detection of cancer-related VOCs.

TOBY, Inc. (New York City, NY, USA) has developed a single urine test that detects 10 cancers, representing over 60% of all new cases globally. This test identifies the unique molecular signature of cancer by combining the precision of spectroscopy, changes in biomarkers (VOCs), and cutting-edge computational algorithms to deliver early, easy, and affordable cancer screening. The process begins with spectroscopy, analyzing the molecular signature of VOCs in urine. These signatures reflect real-time changes in physiology and metabolism. The company’s proprietary AI interprets this complex data to identify early patterns of disease, often before symptoms appear. These algorithms are the result of deep research, development, and training on diverse biological signatures. Every model is engineered to learn from high-dimensional data, capturing subtle, disease-specific patterns with remarkable precision.

Unlike traditional diagnostics that rely on imaging or genetic sequencing, this test focuses on what the body emits in the moment. This approach is fast, scalable, and noninvasive—offering a new pathway for early detection across multiple cancer types. Instead of just detecting cancer, the test interprets the body’s chemical signals using a single, simple urine sample and turns them into actionable insights. TOBY combine truly noninvasive sampling, advanced spectroscopy, and AI for a uniquely accurate, accessible cancer test for multiple cancers.

"Our goal is to support earlier detection, when treatment is most effective and the burden on patients and the healthcare system is reduced," said Dragan Sebišanović, Chief Science Officer of TOBY. "Our technology uses machine learning to help identify molecular patterns associated with early-stage cancer."

Related Links:
TOBY, Inc.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.